Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06950892 · ClinicalTrials.gov registry record
Remote Sputum Collection in Cystic Fibrosis
A clinical trial of Cystic Fibrosis and Infections, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 150
- Enrollment target
- 3
- Study locations
NCT06950892 is a study of Cystic Fibrosis and Infections that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 150 participants, below the 178-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (16% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06950892, a study of Cystic Fibrosis and Infections, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 3
- Study locations
Study Summary
Elexacaftor/Tezacaftor/Ivacaftor or Trikafta improves lung health in people with cystic fibrosis (CF), including decreased cough and mucous production. Diagnosing lung infections has become more challenging due to the decrease in sputum and rise of telehealth services. While the option of collecting sputum samples at home and sending them by mail may be feasible, uncertainty remains about how the collection of samples outside of clinic and delays in testing while in the mail impact infection detection. This study will compare bacterial cultures using sputum samples collected at home versus samples collected in clinic (saline-induced sputum and throat swab). This study seeks to shed light on how valuable home collected samples can be and help us better understand the usefulness of home-collected sputum samples for both clinical and research purposes.
Conditions Studied
Study Locations (3)
Colorado
- National Jewish Health - Denver
Maryland
- Johns Hopkins University - Baltimore
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-01-15 |
| Est. Completion | 2028-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06950892
The ClinicalTrials.gov registry entry for NCT06950892 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (16% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cystic Fibrosis appearing as the primary indexed condition, and to 0 interventions.
NCT06950892 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Colorado, Maryland, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06950892 about?
NCT06950892 is a clinical study titled "Remote Sputum Collection in Cystic Fibrosis". Elexacaftor/Tezacaftor/Ivacaftor or Trikafta improves lung health in people with cystic fibrosis (CF), including decreased cough and mucous production. Diagnosing lung infections has become more challenging due to the decrease in sputum and rise of telehealth services. While the option of collecting...
What is the current status of trial NCT06950892?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-01-15. Estimated completion is 2028-06-30.
What conditions does trial NCT06950892 study?
This clinical trial studies the following conditions: Cystic Fibrosis, Infections.
Who is sponsoring clinical trial NCT06950892?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06950892 being conducted?
This trial has 3 study locations across Colorado, Maryland, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise in Child Health
RECRUITING · NA
-
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
RECRUITING · Phase 2
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
RECRUITING
-
Assessing Tenapanor as a Treatment of CF-related Constipation.
RECRUITING · Phase 3
-
Genetics of Insulin and Incretins in Cystic Fibrosis
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.